Editorial: Impact of COVID-19 on the clinical microbiology laboratory: Preparing for the next pandemic.

Dunbar, Sherry; Babady, Esther; Das, Sanchita; Moore, Catherine

Dunbar, Sherry; Babady, Esther; Das, Sanchita; Moore, Catherine.

Dunbar S; Scientific Affairs, Luminex, A DiaSorin Company, Austin, TX, United States.
Babady E; Clinical Microbiology Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Das S; Department of Laboratory Medicine, Clinical Center National Institutes of Health, Bethesda, MD, United States.
Moore C; Wales Specialist Virology Centre, Public Health Wales NHS Trust, Cardiff, United Kingdom.

Front Cell Infect Microbiol ; 12: 1031436, 2022.

Article in English | MEDLINE | ID: covidwho-2109737

Subject(s)

COVID-19; Pandemics; COVID-19 Testing; Humans; Laboratories; SARS-CoV-2

Keywords

COVID-19; SARS-CoV-2; clinical laboratory; pandemic; strategies

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Diagnostic study / Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Front Cell Infect Microbiol Year: 2022 Document Type: Article Affiliation country: Fcimb.2022.1031436

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google